| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | REPROS THERAPEUTICS INC | 98,000 | 597,000 | 0.50% | Call | |
| 52 | Arrowhead Pharma Inc | 82,133 | 556,000 | 0.47% | ||
| 53 | AGIOS PHARMACEUTICALS INC | 5,000 | 472,000 | 0.40% | ||
| 54 | MACROGENICS INC | 15,000 | 471,000 | 0.39% | ||
| 55 | KARYOPHARM THERAPEUTICS INC COM | 15,000 | 459,000 | 0.38% | ||
| 56 | OMEROS CORP | 20,000 | 441,000 | 0.37% | ||
| 57 | Otonomy Inc | 12,000 | 424,000 | 0.36% | ||
| 58 | ZOGENIX INC | 300,000 | 411,000 | 0.34% | ||
| 59 | AVALANCHE BIOTECHNOLOGIES IN | 10,000 | 405,000 | 0.34% | ||
| 60 | ACELRX PHARMACEUTICALS INC | 99,959 | 386,000 | 0.32% | ||
| 61 | KALOBIOS PHARMACEUTICALS INC | 746,467 | 366,000 | 0.31% | ||
| 62 | GILEAD SCIENCES INC | 3,651 | 358,000 | 0.30% | ||
| 63 | NATIONAL HOLDINGS CORP COM NEW | 89,530 | 349,000 | 0.29% | ||
| 64 | MEI PHARMA INC | 30,000 | 54,000 | 0.05% | ||
| 65 | NEPTUNE TECHNOLOGIES BIORESO | 36 | 1,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-15-001782, filed 2015.05.18).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
